{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:00:48Z","timestamp":1793372448544,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1038\/s41380-025-02901-9","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T08:26:02Z","timestamp":1738225562000},"page":"2966-2979","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Synaptic vulnerability to amyloid-\u03b2 and tau pathologies differentially disrupts emotional and memory neural circuits"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9483-4887","authenticated-orcid":false,"given":"Maria Dolores","family":"Capilla-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7860-6307","authenticated-orcid":false,"given":"Angel","family":"Deprada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5295-0169","authenticated-orcid":false,"given":"Yuniesky","family":"Andrade-Talavera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8936-8201","authenticated-orcid":false,"given":"Irene","family":"Mart\u00ednez-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4953-6562","authenticated-orcid":false,"given":"Heriberto","family":"Coatl-Cuaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9320-5949","authenticated-orcid":false,"given":"Paula","family":"Sotillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8582-8082","authenticated-orcid":false,"given":"Jos\u00e9","family":"Rodr\u00edguez-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8078-6175","authenticated-orcid":false,"given":"Antonio","family":"Rodr\u00edguez-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5683-060X","authenticated-orcid":false,"given":"Arnaldo","family":"Parra-Damas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3692-5657","authenticated-orcid":false,"given":"Carlos A.","family":"Saura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"2901_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jagp.2020.06.006","volume":"29","author":"J Krell-Roesch","year":"2021","unstructured":"Krell-Roesch J, Syrjanen JA, Vassilaki M, Lowe VJ, Vemuri P, Mielke MM, et al. Brain regional glucose metabolism, neuropsychiatric symptoms, and the risk of incident mild cognitive impairment: the mayo clinic study of aging. Am J Geriatr Psychiatry. 2021;29:179\u201391.","journal-title":"Am J Geriatr Psychiatry"},{"key":"2901_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00002093-200401000-00004","volume":"18","author":"TJ Hwang","year":"2004","unstructured":"Hwang TJ, Masterman DL, Ortiz F, Fairbanks LA, Cummings JL. Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alzheimer Dis Assoc Disord. 2004;18:17\u201321.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2901_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/15333175221082834","volume":"37","author":"S Chaudhary","year":"2022","unstructured":"Chaudhary S, Zhornitsky S, Chao HH, van Dyck CH, Li CR. Emotion processing dysfunction in Alzheimer\u2019s disease: an overview of behavioral findings, systems neural correlates, and underlying neural biology. Am J Alzheimers Dis Other Demen. 2022;37:15333175221082834.","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"2901_CR4","doi-asserted-by":"publisher","first-page":"834","DOI":"10.2174\/1567205014666170220150021","volume":"14","author":"J Kim","year":"2017","unstructured":"Kim J, Fischer CE, Schweizer TA, Munoz DG. Gender and pathology-specific effect of Apolipoprotein E genotype on psychosis in Alzheimer\u2019s disease. Curr Alzheimer Res. 2017;14:834\u201340.","journal-title":"Curr Alzheimer Res"},{"key":"2901_CR5","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.3174\/ajnr.A3601","volume":"34","author":"D Holland","year":"2013","unstructured":"Holland D, Desikan RS, Dale AM, McEvoy LK, Alzheimer\u2019s Disease Neuroimaging I. Higher rates of decline for women and apolipoprotein E epsilon4 carriers. AJNR Am J Neuroradiol. 2013;34:2287\u201393.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2901_CR6","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/j.1532-5415.2006.00854.x","volume":"54","author":"P Hollingworth","year":"2006","unstructured":"Hollingworth P, Hamshere ML, Moskvina V, Dowzell K, Moore PJ, Foy C, et al. Four components describe behavioral symptoms in 1120 individuals with late-onset Alzheimer\u2019s disease. J Am Geriatr Soc. 2006;54:1348\u201354.","journal-title":"J Am Geriatr Soc"},{"key":"2901_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13195-022-00991-z","volume":"14","author":"WS Eikelboom","year":"2022","unstructured":"Eikelboom WS, Pan M, Ossenkoppele R, Coesmans M, Gatchel JR, Ismail Z, et al. Sex differences in neuropsychiatric symptoms in Alzheimer\u2019s disease dementia: a meta-analysis. Alzheimers Res Ther. 2022;14:48.","journal-title":"Alzheimers Res Ther"},{"key":"2901_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.brainres.2008.03.079","volume":"1216","author":"C Hirata-Fukae","year":"2008","unstructured":"Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, et al. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res. 2008;1216:92\u2013103.","journal-title":"Brain Res"},{"key":"2901_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.nbd.2016.08.009","volume":"96","author":"T Melnikova","year":"2016","unstructured":"Melnikova T, Park D, Becker L, Lee D, Cho E, Sayyida N, et al. Sex-related dimorphism in dentate gyrus atrophy and behavioral phenotypes in an inducible tTa:APPsi transgenic model of Alzheimer\u2019s disease. Neurobiol Dis. 2016;96:171\u201385.","journal-title":"Neurobiol Dis"},{"key":"2901_CR10","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.bbr.2018.11.022","volume":"359","author":"S Schmid","year":"2019","unstructured":"Schmid S, Rammes G, Blobner M, Kellermann K, Bratke S, Fendl D, et al. Cognitive decline in Tg2576 mice shows sex-specific differences and correlates with cerebral amyloid-\u03b2. Behav Brain Res. 2019;359:408\u201317.","journal-title":"Behav Brain Res"},{"key":"2901_CR11","doi-asserted-by":"publisher","first-page":"e46111","DOI":"10.1371\/journal.pone.0046111","volume":"7","author":"C Bories","year":"2012","unstructured":"Bories C, Guitton MJ, Julien C, Tremblay C, Vandal M, Msaid M, et al. Sex-dependent alterations in social behaviour and cortical synaptic activity coincide at different ages in a model of Alzheimer\u2019s disease. PLoS One. 2012;7:e46111.","journal-title":"PLoS One"},{"key":"2901_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13293-020-00337-0","volume":"11","author":"D Arsenault","year":"2020","unstructured":"Arsenault D, Tremblay C, Emond V, Calon F. Sex-dependent alterations in the physiology of entorhinal cortex neurons in old heterozygous 3xTg-AD mice. Biol Sex Differ. 2020;11:63.","journal-title":"Biol Sex Differ"},{"key":"2901_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2021.147437","volume":"1762","author":"T Pairojana","year":"2021","unstructured":"Pairojana T, Phasuk S, Suresh P, Huang SP, Pakaprot N, Chompoopong S, et al. Age and gender differences for the behavioral phenotypes of 3xTg Alzheimer\u2019s disease mice. Brain Res. 2021;1762:147437.","journal-title":"Brain Res"},{"key":"2901_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01749-w","volume":"17","author":"Y Sun","year":"2020","unstructured":"Sun Y, Guo Y, Feng X, Jia M, Ai N, Dong Y, et al. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3\u03b1 in tau P301S mouse model of Alzheimer\u2019s disease. J Neuroinflammation. 2020;17:72.","journal-title":"J Neuroinflammation"},{"key":"2901_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","volume":"14","author":"MT Ferretti","year":"2018","unstructured":"Ferretti MT, Iulita MF, Cavedo E, Chiesa PA, Schumacher Dimech A, Santuccione Chadha A, et al. Sex differences in Alzheimer disease - the gateway to precision medicine. Nat Rev Neurol. 2018;14:457\u201369.","journal-title":"Nat Rev Neurol"},{"key":"2901_CR16","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/brain\/awab405","volume":"145","author":"E D\u00fczel","year":"2022","unstructured":"D\u00fczel E, Ziegler G, Berron D, Maass A, Schutze H, Cardenas-Blanco A, et al. Amyloid pathology but not APOE \u03b54 status is permissive for tau-related hippocampal dysfunction. Brain. 2022;145:1473\u201385.","journal-title":"Brain"},{"key":"2901_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ana.25395","volume":"85","author":"RA Sperling","year":"2019","unstructured":"Sperling RA, Mormino EC, Schultz AP, Betensky RA, Papp KV, Amariglio RE, et al. The impact of amyloid-\u03b2 and tau on prospective cognitive decline in older individuals. Ann Neurol. 2019;85:181\u201393.","journal-title":"Ann Neurol"},{"key":"2901_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12921-z","volume":"10","author":"TM Harrison","year":"2019","unstructured":"Harrison TM, Maass A, Adams JN, Du R, Baker SL, Jagust WJ. Tau deposition is associated with functional isolation of the hippocampus in aging. Nat Commun. 2019;10:4900.","journal-title":"Nat Commun"},{"key":"2901_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/brain\/awaa395","volume":"144","author":"JB Pereira","year":"2021","unstructured":"Pereira JB, Janelidze S, Ossenkoppele R, Kvartsberg H, Brinkmalm A, Mattsson-Carlgren N, et al. Untangling the association of amyloid-\u03b2 and tau with synaptic and axonal loss in Alzheimer\u2019s disease. Brain. 2021;144:310\u201324.","journal-title":"Brain"},{"key":"2901_CR20","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.biopsych.2020.06.029","volume":"89","author":"T Guo","year":"2021","unstructured":"Guo T, Korman D, Baker SL, Landau SM, Jagust WJ, Alzheimer\u2019s Disease Neuroimaging I. Longitudinal cognitive and biomarker measurements support a unidirectional pathway in Alzheimer\u2019s disease pathophysiology. Biol Psychiatry. 2021;89:786\u201394.","journal-title":"Biol Psychiatry"},{"key":"2901_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/mp.2016.37","volume":"22","author":"TA Pascoal","year":"2017","unstructured":"Pascoal TA, Mathotaarachchi S, Mohades S, Benedet AL, Chung CO, Shin M, et al. Amyloid-\u03b2 and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer\u2019s disease. Mol Psychiatry. 2017;22:306\u201311.","journal-title":"Mol Psychiatry"},{"key":"2901_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113691","volume":"43","author":"M Yu","year":"2024","unstructured":"Yu M, Risacher SL, Nho KT, Wen Q, Oblak AL, Unverzagt FW, et al. Spatial transcriptomic patterns underlying amyloid-beta and tau pathology are associated with cognitive dysfunction in Alzheimer\u2019s disease. Cell Rep. 2024;43:113691.","journal-title":"Cell Rep"},{"key":"2901_CR23","doi-asserted-by":"publisher","first-page":"e0488232023","DOI":"10.1523\/JNEUROSCI.0488-23.2023","volume":"44","author":"CM Kim","year":"2024","unstructured":"Kim CM, Diez I, Bueicheku E, Ahn S, Montal V, Sepulcre J. Spatiotemporal correlation between amyloid and tau accumulations underlies cognitive changes in aging. J Neurosci. 2024;44:e0488232023.","journal-title":"J Neurosci"},{"key":"2901_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.nbd.2009.09.004","volume":"37","author":"F Grueninger","year":"2010","unstructured":"Grueninger F, Bohrmann B, Czech C, Ballard TM, Frey JR, Weidensteiner C, et al. Phosphorylation of Tau at S422 is enhanced by A\u03b2 in TauPS2APP triple transgenic mice. Neurobiol Dis. 2010;37:294\u2013306.","journal-title":"Neurobiol Dis"},{"key":"2901_CR25","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J Gotz","year":"2001","unstructured":"Gotz J, Chen F, van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by A\u03b242 fibrils. Science. 2001;293:1491\u20135.","journal-title":"Science"},{"key":"2901_CR26","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 2001;293:1487\u201391.","journal-title":"Science"},{"key":"2901_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","volume":"24","author":"Z He","year":"2018","unstructured":"He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L, et al. Amyloid-\u03b2 plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med. 2018;24:29\u201338.","journal-title":"Nat Med"},{"key":"2901_CR28","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.ajpath.2017.03.011","volume":"187","author":"RE Bennett","year":"2017","unstructured":"Bennett RE, DeVos SL, Dujardin S, Corjuc B, Gor R, Gonzalez J, et al. Enhanced tau aggregation in the presence of amyloid-\u03b2. Am J Pathol. 2017;187:1601\u201312.","journal-title":"Am J Pathol"},{"key":"2901_CR29","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, et al. Reducing endogenous tau ameliorates amyloid \u03b2-induced deficits in an Alzheimer\u2019s disease mouse model. Science. 2007;316:750\u20134.","journal-title":"Science"},{"key":"2901_CR30","doi-asserted-by":"publisher","first-page":"eaag0481","DOI":"10.1126\/scitranslmed.aag0481","volume":"9","author":"SL DeVos","year":"2017","unstructured":"DeVos SL, Miller RL, Schoch KM, Holmes BB, Kebodeaux CS, Wegener AJ, et al. Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy. Sci Transl Med. 2017;9:eaag0481.","journal-title":"Sci Transl Med"},{"key":"2901_CR31","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"MA Busche","year":"2020","unstructured":"Busche MA, Hyman BT. Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease. Nat Neurosci. 2020;23:1183\u201393.","journal-title":"Nat Neurosci"},{"key":"2901_CR32","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1016\/j.celrep.2019.11.044","volume":"29","author":"EK Pickett","year":"2019","unstructured":"Pickett EK, Herrmann AG, McQueen J, Abt K, Dando O, Tulloch J, et al. Amyloid-\u03b2 and tau cooperate to cause reversible behavioral and transcriptional deficits in a model of Alzheimer\u2019s sisease. Cell Rep. 2019;29:3592\u2013604.e3595.","journal-title":"Cell Rep"},{"key":"2901_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, et al. Dendritic function of tau mediates amyloid-\u03b2 toxicity in Alzheimer\u2019s disease mouse models. Cell. 2010;142:387\u201397.","journal-title":"Cell"},{"key":"2901_CR34","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/brain\/awaa406","volume":"144","author":"M Montero-Crespo","year":"2021","unstructured":"Montero-Crespo M, Dominguez-Alvaro M, Alonso-Nanclares L, DeFelipe J, Blazquez-Llorca L. Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer\u2019s disease. Brain. 2021;144:553\u201373.","journal-title":"Brain"},{"key":"2901_CR35","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron. 2010;68:1067\u201381.","journal-title":"Neuron"},{"key":"2901_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron. 2007;53:337\u201351.","journal-title":"Neuron"},{"key":"2901_CR37","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1016\/j.celrep.2017.03.013","volume":"18","author":"JS Jackson","year":"2017","unstructured":"Jackson JS, Witton J, Johnson JD, Ahmed Z, Ward M, Randall AD, et al. Altered synapse stability in the early stages of tauopathy. Cell Rep. 2017;18:3063\u20138.","journal-title":"Cell Rep"},{"key":"2901_CR38","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s40478-021-01259-7","volume":"9","author":"CM Soto-Faguas","year":"2021","unstructured":"Soto-Faguas CM, Sanchez-Molina P, Saura CA. Loss of presenilin function enhances tau phosphorylation and aggregation in mice. Acta Neuropathol Commun. 2021;9:162.","journal-title":"Acta Neuropathol Commun"},{"key":"2901_CR39","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.neuron.2015.01.025","volume":"85","author":"N Menkes-Caspi","year":"2015","unstructured":"Menkes-Caspi N, Yamin HG, Kellner V, Spires-Jones TL, Cohen D, Stern EA. Pathological tau disrupts ongoing network activity. Neuron. 2015;85:959\u201366.","journal-title":"Neuron"},{"key":"2901_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41593-018-0289-8","volume":"22","author":"MA Busche","year":"2019","unstructured":"Busche MA, Wegmann S, Dujardin S, Commins C, Schiantarelli J, Klickstein N, et al. Tau impairs neural circuits, dominating amyloid-\u03b2 effects, in Alzheimer models in vivo. Nat Neurosci. 2019;22:57\u201364.","journal-title":"Nat Neurosci"},{"key":"2901_CR41","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","volume":"100","author":"B Dejanovic","year":"2018","unstructured":"Dejanovic B, Huntley MA, De Maziere A, Meilandt WJ, Wu T, Srinivasan K, et al. Changes in the synaptic proteome in tauopathy and rescue of tau-induced synapse loss by C1q antibodies. Neuron. 2018;100:1322\u201336.e1327.","journal-title":"Neuron"},{"key":"2901_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15295","volume":"8","author":"L Zhou","year":"2017","unstructured":"Zhou L, McInnes J, Wierda K, Holt M, Herrmann AG, Jackson RJ, et al. Tau association with synaptic vesicles causes presynaptic dysfunction. Nat Commun. 2017;8:15295.","journal-title":"Nat Commun"},{"key":"2901_CR43","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","volume":"20","author":"L Mucke","year":"2000","unstructured":"Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein E, Tatsuno G, et al. High-level neuronal expression of A\u03b21-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci. 2000;20:4050\u20138.","journal-title":"J Neurosci"},{"key":"2901_CR44","volume":"2010","author":"L Gimenez-Llort","year":"2010","unstructured":"Gimenez-Llort L, Garcia Y, Buccieri K, Revilla S, Sunol C, Cristofol R, et al. Gender-specific neuroimmunoendocrine response to treadmill exercise in 3xTg-AD mice. Int J Alzheimers Dis. 2010;2010:128354.","journal-title":"Int J Alzheimers Dis"},{"key":"2901_CR45","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.biopsych.2009.06.015","volume":"67","author":"J Espa\u00f1a","year":"2010","unstructured":"Espa\u00f1a J, Gimenez-Llort L, Valero J, Mi\u00f1ano A, Rabano A, Rodriguez-Alvarez J, et al. Intraneuronal \u03b2-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer\u2019s disease transgenic mice. Biol Psychiatry. 2010;67:513\u201321.","journal-title":"Biol Psychiatry"},{"key":"2901_CR46","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.neuropharm.2012.06.001","volume":"64","author":"N Whittle","year":"2013","unstructured":"Whittle N, Schmuckermair C, Gunduz Cinar O, Hauschild M, Ferraguti F, Holmes A, et al. Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model. Neuropharmacology. 2013;64:414\u201323.","journal-title":"Neuropharmacology"},{"key":"2901_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100654","volume":"2","author":"J Kang","year":"2021","unstructured":"Kang J, Watanabe H, Shen J. Protocols for assessing neurodegenerative phenotypes in Alzheimer\u2019s mouse models. STAR Protoc. 2021;2:100654.","journal-title":"STAR Protoc"},{"key":"2901_CR48","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/bioinformatics\/btu781","volume":"31","author":"D Gaidatzis","year":"2015","unstructured":"Gaidatzis D, Lerch A, Hahne F, Stadler MB. QuasR: quantification and annotation of short reads in R. Bioinformatics. 2015;31:1130\u20132.","journal-title":"Bioinformatics"},{"key":"2901_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"2901_CR50","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u201397.","journal-title":"Nucleic Acids Res"},{"key":"2901_CR51","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","volume":"53","author":"DP Wightman","year":"2021","unstructured":"Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Holland D, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat Genet. 2021;53:1276\u201382.","journal-title":"Nat Genet"},{"key":"2901_CR52","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, Kucukali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54:412\u201336.","journal-title":"Nat Genet"},{"key":"2901_CR53","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1016\/j.cell.2023.09.023","volume":"186","author":"AL Boxer","year":"2023","unstructured":"Boxer AL, Sperling R. Accelerating Alzheimer\u2019s therapeutic development: the past and future of clinical trials. Cell. 2023;186:4757\u201372.","journal-title":"Cell"},{"key":"2901_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"2901_CR55","doi-asserted-by":"publisher","first-page":"e1391","DOI":"10.1212\/WNL.0000000000207663","volume":"101","author":"C Monteiro","year":"2023","unstructured":"Monteiro C, Toth B, Brunstein F, Bobbala A, Datta S, Ceniceros R, et al. Randomized phase II study of the safety and efficacy of semorinemab in participants with mild-to-moderate Alzheimer disease: Lauriet. Neurology. 2023;101:e1391\u2013401.","journal-title":"Neurology"},{"key":"2901_CR56","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson 3rd","year":"2023","unstructured":"Wilson DM, 3rd, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, et al. Hallmarks of neurodegenerative diseases. Cell. 2023;186:693\u2013714.","journal-title":"Cell"},{"key":"2901_CR57","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1523\/JNEUROSCI.2111-20.2020","volume":"41","author":"X Chen","year":"2021","unstructured":"Chen X, Cassady KE, Adams JN, Harrison TM, Baker SL, Jagust WJ. Regional tau effects on prospective cognitive change in cognitively normal older adults. J Neurosci. 2021;41:366\u201375.","journal-title":"J Neurosci"},{"key":"2901_CR58","doi-asserted-by":"publisher","first-page":"786","DOI":"10.2353\/ajpath.2008.070904","volume":"172","author":"D Terwel","year":"2008","unstructured":"Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, et al. Amyloid activates GSK-3\u03b2 to aggravate neuronal tauopathy in bigenic mice. Am J Pathol. 2008;172:786\u201398.","journal-title":"Am J Pathol"},{"key":"2901_CR59","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41586-024-07871-6","volume":"633","author":"GS Green","year":"2024","unstructured":"Green GS, Fujita M, Yang HS, Taga M, Cain A, McCabe C, et al. Cellular communities reveal trajectories of brain ageing and Alzheimer\u2019s disease. Nature. 2024;633:634\u201345.","journal-title":"Nature"},{"key":"2901_CR60","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.neuron.2023.04.020","volume":"111","author":"M Colom-Cadena","year":"2023","unstructured":"Colom-Cadena M, Davies C, Sirisi S, Lee JE, Simzer EM, Tzioras M, et al. Synaptic oligomeric tau in Alzheimer\u2019s disease - A potential culprit in the spread of tau pathology through the brain. Neuron. 2023;111:2170\u201383.e2176.","journal-title":"Neuron"},{"key":"2901_CR61","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3233\/JAD-180276","volume":"64","author":"H Ni","year":"2018","unstructured":"Ni H, Xu M, Zhan GL, Fan Y, Zhou H, Jiang HY, et al. The GWAS risk genes for depression may be actively involved in Alzheimer\u2019s disease. J Alzheimers Dis. 2018;64:1149\u201361.","journal-title":"J Alzheimers Dis"},{"key":"2901_CR62","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.1093\/cercor\/bhac012","volume":"32","author":"KF Shen","year":"2022","unstructured":"Shen KF, Yue J, Wu ZF, Wu KF, Zhu G, Yang XL, et al. Fibroblast growth factor 13 is involved in the pathogenesis of temporal lobe epilepsy. Cereb Cortex. 2022;32:5259\u201372.","journal-title":"Cereb Cortex"},{"key":"2901_CR63","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.1007\/s12035-023-03426-4","volume":"60","author":"C Kjaer","year":"2023","unstructured":"Kjaer C, Palasca O, Barzaghi G, Bak LK, Durhuus RKJ, Jakobsen E, et al. Differential expression of the \u03b23 subunit of voltage-gated Ca2+ channel in mesial temporal lobe epilepsy. Mol Neurobiol. 2023;60:5755\u201369.","journal-title":"Mol Neurobiol"},{"key":"2901_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24741-0","volume":"8","author":"A Van der Jeugd","year":"2018","unstructured":"Van der Jeugd A, Parra-Damas A, Baeta-Corral R, Soto-Faguas CM, Ahmed T, LaFerla FM, et al. Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice. Sci Rep. 2018;8:6431.","journal-title":"Sci Rep"},{"key":"2901_CR65","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.biopsych.2022.01.012","volume":"92","author":"M Johansson","year":"2022","unstructured":"Johansson M, Stomrud E, Johansson PM, Svenningsson A, Palmqvist S, Janelidze S, et al. Development of apathy, anxiety, and depression in cognitively unimpaired older adults: Effects of Alzheimer\u2019s disease pathology and cognitive decline. Biol Psychiatry. 2022;92:34\u201343.","journal-title":"Biol Psychiatry"},{"key":"2901_CR66","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1038\/s41380-021-01257-0","volume":"26","author":"LE Arroyo-Garcia","year":"2021","unstructured":"Arroyo-Garcia LE, Isla AG, Andrade-Talavera Y, Balleza-Tapia H, Loera-Valencia R, Alvarez-Jimenez L, et al. Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the App(NL-G-F) mouse model of Alzheimer\u2019s disease. Mol Psychiatry. 2021;26:5557\u201367.","journal-title":"Mol Psychiatry"},{"key":"2901_CR67","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3233\/JAD-220040","volume":"88","author":"K Wolfova","year":"2022","unstructured":"Wolfova K, Creese B, Aarsland D, Ismail Z, Corbett A, Ballard C, et al. Gender\/sex differences in the association of mild behavioral impairment with cognitive aging. J Alzheimers Dis. 2022;88:345\u201355.","journal-title":"J Alzheimers Dis"},{"key":"2901_CR68","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/ana.25878","volume":"88","author":"RF Buckley","year":"2020","unstructured":"Buckley RF, Scott MR, Jacobs HIL, Schultz AP, Properzi MJ, Amariglio RE, et al. Sex mediates relationships between regional tau pathology and cognitive decline. Ann Neurol. 2020;88:921\u201332.","journal-title":"Ann Neurol"},{"key":"2901_CR69","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.trci.2015.07.001","volume":"1","author":"KA Lin","year":"2015","unstructured":"Lin KA, Choudhury KR, Rathakrishnan BG, Marks DM, Petrella JR, Doraiswamy PM, et al. Marked gender differences in progression of mild cognitive impairment over 8 years. Alzheimers Dement (N Y). 2015;1:103\u201310.","journal-title":"Alzheimers Dement (N Y)"},{"key":"2901_CR70","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/archpsyc.62.6.685","volume":"62","author":"LL Barnes","year":"2005","unstructured":"Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005;62:685\u201391.","journal-title":"Arch Gen Psychiatry"},{"key":"2901_CR71","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neurobiolaging.2019.10.008","volume":"85","author":"M Johansson","year":"2020","unstructured":"Johansson M, Stomrud E, Lindberg O, Westman E, Johansson PM, van Westen D, et al. Apathy and anxiety are early markers of Alzheimer\u2019s disease. Neurobiol Aging. 2020;85:74\u201382.","journal-title":"Neurobiol Aging"},{"key":"2901_CR72","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3233\/JAD-210020","volume":"82","author":"WJ Cai","year":"2021","unstructured":"Cai WJ, Tian Y, Ma YH, Dong Q, Tan L, Yu JT, et al. Associations of anxiety with amyloid, tau, and neurodegeneration in older adults without dementia: a longitudinal study. J Alzheimers Dis. 2021;82:273\u201383.","journal-title":"J Alzheimers Dis"},{"key":"2901_CR73","volume":"7","author":"C Tissot","year":"2021","unstructured":"Tissot C, Therriault J, Pascoal TA, Chamoun M, Lussier FZ, Savard M, et al. Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer\u2019s disease. Alzheimers Dement. 2021;7:e12154.","journal-title":"Alzheimers Dement"},{"key":"2901_CR74","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1212\/WNL.0000000000011081","volume":"96","author":"J Therriault","year":"2021","unstructured":"Therriault J, Pascoal TA, Savard M, Benedet AL, Chamoun M, Tissot C, et al. Topographic distribution of amyloid-\u03b2, tau, and atrophy in patients with behavioral\/dysexecutive Alzheimer disease. Neurology. 2021;96:e81\u201392.","journal-title":"Neurology"},{"key":"2901_CR75","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/brain\/awx052","volume":"140","author":"RM Nisbet","year":"2017","unstructured":"Nisbet RM, Van der Jeugd A, Leinenga G, Evans HT, Janowicz PW, Gotz J. Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model. Brain. 2017;140:1220\u201330.","journal-title":"Brain"},{"key":"2901_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12170","volume":"7","author":"M Anglada-Huguet","year":"2021","unstructured":"Anglada-Huguet M, Rodrigues S, Hochgrafe K, Mandelkow E, Mandelkow EM. Inhibition of Tau aggregation with BSc3094 reduces Tau and decreases cognitive deficits in rTg4510 mice. Alzheimers Dement (N Y). 2021;7:e12170.","journal-title":"Alzheimers Dement (N Y)"},{"key":"2901_CR77","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13195-020-00743-x","volume":"13","author":"J Di","year":"2021","unstructured":"Di J, Siddique I, Li Z, Malki G, Hornung S, Dutta S, et al. The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice. Alzheimers Res Ther. 2021;13:6.","journal-title":"Alzheimers Res Ther"},{"key":"2901_CR78","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1093\/brain\/awq258","volume":"133","author":"K Bossers","year":"2010","unstructured":"Bossers K, Wirz KT, Meerhoff GF, Essing AH, van Dongen JW, Houba P, et al. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer\u2019s disease. Brain. 2010;133:3699\u2013723.","journal-title":"Brain"},{"key":"2901_CR79","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.neurobiolaging.2012.11.024","volume":"34","author":"NC Berchtold","year":"2013","unstructured":"Berchtold NC, Coleman PD, Cribbs DH, Rogers J, Gillen DL, Cotman CW. Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer\u2019s disease. Neurobiol Aging. 2013;34:1653\u201361.","journal-title":"Neurobiol Aging"},{"key":"2901_CR80","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neuropharm.2013.10.018","volume":"79","author":"SE Counts","year":"2014","unstructured":"Counts SE, Alldred MJ, Che S, Ginsberg SD, Mufson EJ. Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment. Neuropharmacology. 2014;79:172\u20139.","journal-title":"Neuropharmacology"},{"key":"2901_CR81","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.semcdb.2022.05.007","volume":"139","author":"CA Saura","year":"2023","unstructured":"Saura CA, Deprada A, Capilla-Lopez MD, Parra-Damas A. Revealing cell vulnerability in Alzheimer\u2019s disease by single-cell transcriptomics. Semin Cell Dev Biol. 2023;139:73\u201383.","journal-title":"Semin Cell Dev Biol"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02901-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02901-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02901-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T05:35:07Z","timestamp":1757136907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02901-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":81,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2901"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-02901-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.04.12.536603","asserted-by":"object"}]},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"19 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}